The company is not involved in the vaccine business
August 18, 2025
Source: drugdu
88
Everyday AI Newsflash: An investor asked on the investor interaction platform: Has the company participated in the research and development of an AIDS vaccine? Does the company have this technology?
Tiantan Biological (600161.SH) stated on the investor interaction platform on August 15 that the company is not involved in the vaccine business. The company's main business is the research and development, production and sales of blood products, and it is in the blood products industry. At present, the company has launched three major categories of products, namely human albumin, human immunoglobulin and human coagulation factor, as well as recombinant coagulation factor products.
https://finance.eastmoney.com/a/202508153485469676.html
By editor
Copyright©2025 Ddu. All rights reserved.
Read more on
- Breaking the Mold and Forging a New Path! From Insulin Technology Pioneer to Global Innovation Competitor December 4, 2025
- A subsidiary of Kingfriend Pharmaceutical Co., Ltd. has received FDA approval for its self-developed injectable dapavancin December 4, 2025
- Major ophthalmic new drug successfully completed Phase III trials December 4, 2025
- Simcere Pharmaceutical and Wangshan Wangshui have reached an exclusive licensing agreement for deuterium remidevir hydrobromide for new indications such as RSV infection December 4, 2025
- SAL0140 tablets approved for clinical trials for the treatment of chronic kidney disease December 4, 2025
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
